Agendia logo

Agendia

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast cancer journey.

209 employees · est. 2003 · Irvine, United States

VS
SkylineDx BV logo

SkylineDx BV

We serve society with science based solutions.

74 employees · est. 2013 · Rotterdam, The Netherlands

Agendia is the older company (2003 vs 2013); Agendia is the larger of the two.

Side-by-Side Comparison

Agendia SkylineDx BV
Founded
2003 older 2013
Headquarters
Irvine, United States Rotterdam, The Netherlands
Employees
209 larger 74
Industry
Biotechnology, Health Care, Life Sciences Biotechnology, Health Care
Funding Stage
Private Equity Series Unknown
Total Funding
$176.05M $20.00M
Funding Rounds
9 3
Services
Genomic Testing Platforms, Molecular Subtyping, Data Analysis for Treatment Planning, Clinical Trial Support Not tracked yet
Target Customers
Healthcare Providers, Medical Institutions, Breast Cancer Patients, Patient Advocacy Partners, Research Institutions Not tracked yet
Taxonomy
Precision Oncology, Genomic Profiling, Molecular Subtyping, Cancer Recurrence Assay, Clinical Evidence, Real World Evidence, Treatment Guidelines, Next-Generation Diagnostics, Personalized Treatment, Breast Cancer, Genomic Testing, Medical Research, Digital Treatment Tools, Clinical Decision Support, Biopsy Analysis Precision Medicine, Genomic Testing, Personalized Treatment, Cancer Diagnosis, Genetic Research, Gene Signature Testing, Disease Treatment, Patient Advocacy, Medical Innovation, Quality Of Life, Healthcare Solutions
Website
agendia.com skylinedx.com
Agendia logo

About Agendia

Agendia is a precision oncology company headquartered in Irvine, California, committed to providing patients with early stage breast cancer and their physicians the information they need to make the best treatment decisions. The company currently offers two commercially-available genomic profiling t...

SkylineDx BV logo

About SkylineDx BV

SkylineDx BV SkylineDx BV is a biotechnology and healthcare company founded in 2005, based in The Netherlands. The company's mission is to improve patients' quality of life by providing personalized insights at the genomic level of their disease through gene signature-based diagnostic testing. The...

We will tell you when either one moves

BounceWatch watches Agendia and SkylineDx BV for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Agendia and SkylineDx BV — by email.

Frequently Asked Questions

Agendia — MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast cancer journey.. SkylineDx BV — We serve society with science based solutions. . Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Agendia has raised $176.05M while SkylineDx BV has raised $20.00M.
Agendia and SkylineDx BV operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Agendia with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Agendia on 7 Feb 2025, and SkylineDx BV on 11 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy